Literature DB >> 26853952

Comparison of Outcomes of Patients With Sepsis With Versus Without Acute Myocardial Infarction and Comparison of Invasive Versus Noninvasive Management of the Patients With Infarction.

Nathaniel R Smilowitz1, Navdeep Gupta2, Yu Guo1, Sripal Bangalore3.   

Abstract

Patients hospitalized with sepsis may be predisposed to acute myocardial infarction (AMI). The incidence, treatment, and outcomes of AMI in sepsis have not been studied. We analyzed data from the National Inpatient Sample from 2002 to 2011 for patients with a diagnosis of sepsis. The incidence of AMI as a nonprimary diagnosis was evaluated. Propensity score matching was used to identify a cohort of patients with secondary AMI and sepsis with similar baseline characteristics who were managed invasively (defined as cardiac catheterization, percutaneous coronary intervention [PCI], or coronary artery bypass graft [CABG] surgery) or conservatively. The primary outcome was in-hospital all-cause mortality. A total of 2,602,854 patients had a diagnosis of sepsis. AMI was diagnosed in 118,183 patients (4.5%), the majority with non-ST elevation AMI (71.4%). In-hospital mortality was higher in patients with AMI and sepsis than those with sepsis alone (35.8% vs 16.8%, p <0.0001; adjusted odds ratio 1.24, 95% CI 1.22 to 1.26). In patients with AMI, 11,899 patients (10.1%) underwent an invasive management strategy, in which 4,668 patients (39.2%) underwent revascularization. PCI was performed in 3,413 patients (73.1%), CABG in 1,165 (25.0%), and both CABG and PCI in 90 patients (1.9%). In a propensity-matched cohort of 23,708 patients with AMI, invasive management was associated with a lower mortality than conservative management (19.0% vs 33.4%, p <0.001; odds ratio 0.47, 95% CI 0.44 to 0.50). In subgroups that underwent revascularization, the odds of mortality were consistently lower than corresponding matched subjects from the conservative group. In conclusion, myocardial infarction not infrequently complicates sepsis and is associated with a significant increase in in-hospital mortality. Patients managed invasively had a lower mortality than those managed conservatively.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26853952     DOI: 10.1016/j.amjcard.2015.12.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Cardiovascular Events and Hospital Deaths Among Patients With Severe Sepsis.

Authors:  Nirav Patel; Navkaranbir S Bajaj; Rajkumar Doshi; Ankur Gupta; Rajat Kalra; Amitoj Singh; Lorenzo Berra; Garima Arora; Sumanth D Prabhu; Pankaj Arora
Journal:  Am J Cardiol       Date:  2019-02-07       Impact factor: 2.778

2.  Occurrence and Impact of Gastrointestinal Bleeding and Major Adverse Cardiovascular Events during Sepsis: A 15-Year Observational Study.

Authors:  Ming-Shun Hsieh; Shu-Hui Liao; Vivian Chia-Rong Hsieh; Chorng-Kuang How
Journal:  Emerg Med Int       Date:  2020-09-27       Impact factor: 1.112

3.  Troponin I Cutoff for Non-ST-Segment Elevation Myocardial Infarction in Sepsis.

Authors:  Meng-Ko Tsai; Chao-Hung Lai; Chia-Lien Hung; Keng-Yi Wu
Journal:  Mediators Inflamm       Date:  2022-05-27       Impact factor: 4.529

4.  Mortality in sepsis: Comparison of outcomes between patients with demand ischemia, acute myocardial infarction, and neither demand ischemia nor acute myocardial infarction.

Authors:  Mahek Shah; Soumya Patnaik; Obiora Maludum; Brijesh Patel; Byomesh Tripathi; Manyoo Agarwal; Lohit Garg; Sahil Agrawal; Ulrich P Jorde; Matthew W Martinez
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

5.  Extra-pancreatic complications, especially hemodialysis predict mortality and length of stay, in ICU patients admitted with acute pancreatitis.

Authors:  Darshan Kothari; Maarten R Struyvenberg; Michael C Perillo; Ghideon Ezaz; Steven D Freedman; Sunil G Sheth
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-03-03

6.  Impact of post-sepsis cardiovascular complications on mortality in sepsis survivors: a population-based study.

Authors:  Meng-Huan Wu; Po-Yang Tsou; Yu-Hsun Wang; Meng-Tse Gabriel Lee; Christin Chih Ting Chao; Wan-Chien Lee; Si-Huei Lee; Jiun-Ruey Hu; Jiunn-Yih Wu; Shy-Shin Chang; Chien-Chang Lee
Journal:  Crit Care       Date:  2019-09-02       Impact factor: 9.097

7.  Associations of antithrombotic agent use with clinical outcomes in critically ill patients with troponin I elevation in the absence of acute coronary syndrome.

Authors:  Chuan-Tsai Tsai; Ya-Wen Lu; Ruey-Hsing Chou; Yi-Lin Tsai; Ming-Ren Kuo; Jiun-Yu Guo; Chi-Ting Lu; Chin-Sung Kuo; Po-Hsun Huang
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

8.  Effect of timing of coronary revascularization in patients with post-infectious myocardial infarction.

Authors:  Chuan-Tsai Tsai; Ya-Wen Lu; Ruey-Hsing Chou; Chin-Sung Kuo; Po-Hsun Huang; Cheng-Hsueh Wu; Shao-Sung Huang
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

9.  Access to reperfusion therapy and mortality outcomes in patients with ST-segment elevation myocardial infarction under universal health coverage in Thailand.

Authors:  Chulaporn Limwattananon; Jiraphan Jaratpatthararoj; Jutatip Thungthong; Phumtham Limwattananon; Amnat Kitkhuandee
Journal:  BMC Cardiovasc Disord       Date:  2020-03-06       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.